| Leonard T Walsh, MD | |
|
1860 Fair Ave Ste A, Honesdale, PA 18431-2108 | |
| (570) 253-3391 | |
| (570) 253-1811 |
| Full Name | Leonard T Walsh |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 7 Years |
| Location | 1860 Fair Ave Ste A, Honesdale, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407389554 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MT214317 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Regional Hospital Of Scranton | Scranton, PA | Hospital |
| Wayne Memorial Hospital | Honesdale, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeastern Gastroenterology Associates, Pc | 7113990912 | 9 |
News Archive
Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has granted a Breakthrough Therapy designation to cyclic pyranopterin monophosphate (cPMP, or ALXN1101), an enzyme co-factor replacement therapy for the treatment of patients with molybdenum cofactor deficiency type A, a severe and life-threatening, ultra-rare, genetic metabolic disorder that causes catastrophic and irreversible neurologic damage within the first weeks of life.
With the disease burden of AIDS, tuberculosis, and malaria expected to make up less than 15 percent of the total disease burden in sub-Saharan Africa (SSA) by 2030, and non-communicable diseases to account for nearly 40 percent of the total in the region, "[a] revision of the approach to research and health care in SSA is therefore urgently needed, but international donors and health communities have generally been slow to respond to the changing environment."
In a recent study, researchers develop a new high-throughput assay that allows for rapid screening of potential inhibitors.
Over the last few years, the U.S. increasingly has "turned its attention" to the HIV/AIDS "crisis" in Africa even though in "large parts of this country, America is Africa," Patrick Moore, author of "Tweaked: A Crystal Meth Memoir," writes in a Long Island Newsday opinion piece.
› Verified 4 days ago
| Entity Name | Guthrie Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962451153 PECOS PAC ID: 6002728656 Enrollment ID: O20040301000571 |
News Archive
Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has granted a Breakthrough Therapy designation to cyclic pyranopterin monophosphate (cPMP, or ALXN1101), an enzyme co-factor replacement therapy for the treatment of patients with molybdenum cofactor deficiency type A, a severe and life-threatening, ultra-rare, genetic metabolic disorder that causes catastrophic and irreversible neurologic damage within the first weeks of life.
With the disease burden of AIDS, tuberculosis, and malaria expected to make up less than 15 percent of the total disease burden in sub-Saharan Africa (SSA) by 2030, and non-communicable diseases to account for nearly 40 percent of the total in the region, "[a] revision of the approach to research and health care in SSA is therefore urgently needed, but international donors and health communities have generally been slow to respond to the changing environment."
In a recent study, researchers develop a new high-throughput assay that allows for rapid screening of potential inhibitors.
Over the last few years, the U.S. increasingly has "turned its attention" to the HIV/AIDS "crisis" in Africa even though in "large parts of this country, America is Africa," Patrick Moore, author of "Tweaked: A Crystal Meth Memoir," writes in a Long Island Newsday opinion piece.
› Verified 4 days ago
| Entity Name | Northeastern Gastroenterology Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942211248 PECOS PAC ID: 7113990912 Enrollment ID: O20040819000149 |
News Archive
Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has granted a Breakthrough Therapy designation to cyclic pyranopterin monophosphate (cPMP, or ALXN1101), an enzyme co-factor replacement therapy for the treatment of patients with molybdenum cofactor deficiency type A, a severe and life-threatening, ultra-rare, genetic metabolic disorder that causes catastrophic and irreversible neurologic damage within the first weeks of life.
With the disease burden of AIDS, tuberculosis, and malaria expected to make up less than 15 percent of the total disease burden in sub-Saharan Africa (SSA) by 2030, and non-communicable diseases to account for nearly 40 percent of the total in the region, "[a] revision of the approach to research and health care in SSA is therefore urgently needed, but international donors and health communities have generally been slow to respond to the changing environment."
In a recent study, researchers develop a new high-throughput assay that allows for rapid screening of potential inhibitors.
Over the last few years, the U.S. increasingly has "turned its attention" to the HIV/AIDS "crisis" in Africa even though in "large parts of this country, America is Africa," Patrick Moore, author of "Tweaked: A Crystal Meth Memoir," writes in a Long Island Newsday opinion piece.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leonard T Walsh, MD 1860 Fair Ave Ste A, Honesdale, PA 18431-2108 Ph: (570) 253-3391 | Leonard T Walsh, MD 1860 Fair Ave Ste A, Honesdale, PA 18431-2108 Ph: (570) 253-3391 |
News Archive
Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has granted a Breakthrough Therapy designation to cyclic pyranopterin monophosphate (cPMP, or ALXN1101), an enzyme co-factor replacement therapy for the treatment of patients with molybdenum cofactor deficiency type A, a severe and life-threatening, ultra-rare, genetic metabolic disorder that causes catastrophic and irreversible neurologic damage within the first weeks of life.
With the disease burden of AIDS, tuberculosis, and malaria expected to make up less than 15 percent of the total disease burden in sub-Saharan Africa (SSA) by 2030, and non-communicable diseases to account for nearly 40 percent of the total in the region, "[a] revision of the approach to research and health care in SSA is therefore urgently needed, but international donors and health communities have generally been slow to respond to the changing environment."
In a recent study, researchers develop a new high-throughput assay that allows for rapid screening of potential inhibitors.
Over the last few years, the U.S. increasingly has "turned its attention" to the HIV/AIDS "crisis" in Africa even though in "large parts of this country, America is Africa," Patrick Moore, author of "Tweaked: A Crystal Meth Memoir," writes in a Long Island Newsday opinion piece.
› Verified 4 days ago
Dr. David Dewitt Reynolds, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1860 Fair Ave., Suite A, Honesdale, PA 18431 Phone: 570-253-3391 Fax: 570-253-1811 | |
Clifford Carrol, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 601 Park St, Honesdale, PA 18431 Phone: 570-253-8185 | |
Dr. Matthew James Downey, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1860 Fair Avenue, Suite A, Honesdale, PA 18431 Phone: 570-253-3391 Fax: 570-253-1811 | |
Dr. Matthew Timothy Kuber, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 310 Sunrise Ave, Honesdale, PA 18431 Phone: 570-253-4255 Fax: 570-253-6844 | |
Dr. Joseph Laureti, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 601 Park St, Honesdale, PA 18431 Phone: 570-253-8601 Fax: 570-253-8348 | |
Walid Mohamed Hassan, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 601 Park St, Honesdale, PA 18431 Phone: 570-253-8601 Fax: 570-253-8348 | |
William Russell Dewar Iii, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1839 Fair Ave, Honesdale, PA 18431 Phone: 570-251-6500 Fax: 570-253-8195 |